Abstract:
Onychomycosis is the most frequent nail disease, accounting for about a half of all nail abnormalities and for one third of all mycotic infections of the skin. The frequency of onychomycosis is found to be about 3–8% of general population, with toenail involvement being 4–7 times more frequent than fingernail ones. Although toenail onychomycosis is not a life-threatening disease, it cannot be considered as a cosmetic problem only. Besides many complications like bacterial cellulitis or allergic reactions, in several studies toenail onychomycosis has also been shown to significantly alter the patients’ quality of life (QoL). Numerous onychomycosis-specific questionnaires have been developed to assess QoL in onychomycosis patients as general health questionnaires usually do not identify well problems of patients with skin diseases. It was observed that affected by toenail onychomycosis persons experienced reduced self-confidence, embarrassment, and were less willing to participate in social and leisure activities. In addition, it was found that 33.4% of patients with onychomycosis had slightly decreased QoL, 30% moderately decreased, 21% severely decreased and 0.8% very severely altered QoL, while only 14.9% of patients demonstrated normal QoL. The degree of influence of toenail onychomycosis on patients’ QoL depends on several disease-related and demographic parameters, including, but not limited to duration and type of onychomycosis, number of involved toenails, age, gender, place of living, and education. Summarizing, toenail onychomycosis is a common disease which significantly influences patients’ psyche. Based on own experience and literature data it could be concluded that toenail onychomycosis causes marked decrease of QoL in a reasonable number of patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- DLQI:
-
dermatology life quality index
- MCID:
-
minimal clinically important difference
- ODSQ:
-
onychomycosis disease-specific questionnaire
- QoL:
-
quality of life
References
Baran R, Dawber RPR. (1994). Diseases of the Nails and their Management. Blackwell Science, Oxford.
Arrese JE, Piérard-Franchimont C, Piérard GE. (1996). Am J Dermatopathol. 18: 196–198.
Both H, Essink-Bot M-L, Busschbach J, Nijsten T. (2007). J Invest Dermatol. 127: 2726–2739.
Drake L. (1995). AIDS Patient Care. 9(Suppl 1): S15–S17.
Drake LA, Scher RK, Smith EB, Faich GA, Smith SL, Hong JJ, Stiller MJ. (1998). J Am Acad Dermatol. 38: 702–704.
Drake LA, Patrick DL, Fleckman P, Andre J, Baran R, Haneke E, Sapede C, Tosti A. (1999). J Am Acad Dermatol. 41: 189–196.
Dupuy HJ. (1984). In: Wenger NK, Mattson ME, Furberg CD, Elinson J (eds.) Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. Le Jacq, New York, pp. 170–183.
Elewski BE. (1997). Int J Dermatol. 36: 754–756.
Finlay AY, Khan GK. (1994). Clin Exp Dermatol. 19: 210–214.
Firooz A, Khamesipour A, Dowlati Y. (2003). J Dermatol Treat. 14: 95–98.
Fleming JS, Courtney BE. (1984). J Pers Soc Psychol. 46: 404–421.
Gupta AK, Jain HC, Lynde CW, Watteel GN, Summerbell RC. (1997). Int J Dermatol. 36: 783–787.
Heikkilä H, Stubb S. (1995). Br J Dermatol. 133: 699–701.
Hrehorów E, Reich A, Szepietowski J. (2007). Dermatol Klin. 9: 19–23.
Katsambas A, Abeck D, Haneke E, van de Kerkhof P, Burzykowski T, Molenberghs G, Marynissen G. (2005). J Eur Acad Dermatol Venereol. 19: 191–195.
Kowalczuk-Zieleniec E, Nowicki E, Majkowicz M. (2002). J Eur Acad Dermatol Venereol. 16(Suppl 1): 248.
Lubeck DP. (1998). J Am Acad Dermatol. 38: S64–S68.
Lubeck DP, Patrick DL, McNulty P, Fifer SK, Birnbaum J. (1993). Qual Life Res. 2: 341–348.
Lubeck DP, Gause D, Schein JR, Prebil LE, Potter LP. (1999a). Qual Life Res. 8: 121–129.
Lubeck DP, Schein JR, Gause D, Prebil LA, Potter LP. (1999b). J Clin Outcomes Manage. 6: 37–42.
Millikan LE, Powell DW, Drake LA. (1999). Int J Dermatol. 38(Suppl. 2): 13–16.
Potter LP, Mathias SD, Raut M, Kianifard F, Tavakkol A. (2006). Health Qual Life Outcomes. 4: 50.
Reich A, Nowicka D, Szepietowski J. (2005). Dermatol Klin. 7: 79–81.
Reich A, Chrostowska-Plak D, Szepietowski JC. (2007). Acta Derm Venereol. 87: 471–472.
Roberts DT. (1992). Br J Dermatol. 126: 23–37.
Roberts DT. (1999). Br J Dermatol. 141(Suppl. 56): 1–4.
Roujeau JC, Sigurgeirsson B, Korting HC .(2004). Dermatology. 209: 301–307.
Sikora M, Pachołek T, Soter K, Szepietowski J. (2000). Mikol Lek. 7: 145–151.
Scher RK. (1994). Br J Dermatol. 130(Suppl. 43): 15.
Shaw JW, Joish VN, Coons SJ. (2002). Pharmacoeconomics. 20: 23–36.
Stewart AL., Ware JE. (1992). Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Duke University Press, Durham.
Szepietowski JC. (2004). Mikol Lek. 11: 119–128.
Szepietowski JC, Reich A, Garłowska E, Kulig M, Baran E. (2006a). Arch Dermatol. 142: 1279–1284.
Szepietowski JC, Reich A, Woźniak M, Baran E. (2006b). Mikol Lek. 13: 193–198.
Szepietowski J, Półgrabio-Szwedo K, Reich A, Pacan P, Baran E. (2007a). Mikol Lek. 14: 59–62.
Szepietowski JC, Reich A, Pacan P, Garłowska E, Baran E. (2007b). J Eur Acad Dermatol Venerol. 21: 491–496.
Szepietowski JC, Reich A, Wesolowska-Szepietowska E, Baran E. (2007c). Dermatol Klin. 9(Suppl. 1): 41.
Temkin NR, Dikmen S, Machamer J, McLean A. (1989). Med Care. 27(Suppl 3): S44–S53.
Turner RR, Testa MA. (2000). Qual Life Res. 9: 39–53.
Ware J, Kosinski M, Keller SD. (1996). Med Care. 34: 220–233.
Warshaw EM, Foster JK, Cham PMH, Grill JP, Chen SC. (2007). Int J Dermatol. 46: 1279–1286.
Whittam LR, Hay RJ. (1997). Clin Exp Dermatol. 22: 87–89.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Reich, A., Szepietowski, J.C. (2010). Quality of Life in Toenail Onychomycosis. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_223
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_223
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine